A. Aszalos

发表

Isolation and structure elucidation of a novel griseorhodin.

P. Roller, J. Chan, R. Stroshane, 1979, The Journal of antibiotics.

Specific cell-signal targets for cancer chemotherapy

A. Aszalos, 2002, Archives of pharmacal research.

P-glycoprotein, expressed in multidrug resistant cells, is not responsible for alterations in membrane fluidity or membrane potential.

M. Gottesman, J. Annereau, Xing-jie Liang, 2003, Cancer research.

Cytoskeletal modulation of plasma membrane events induced by interferon-alpha.

A. Aszalos, E. Bálint, M. Cheng, 1992, Journal of interferon research.

Depolymerization of microtubules alters membrane potential and affects the motional freedom of membrane proteins.

M. Gottesman, S. Damjanovich, A. Aszalos, 1986, Biochemistry.

The L‐selectin (Leu8) molecule is associated with the TcR/CD3 receptor; fluorescence energy transfer measurements on live cells

P. S. Pine, J. Weaver, P. Rao, 1994, Immunology and cell biology.

COMPARISON OF THE IN WTRO AND BIOPHYSICAL EFFECTS ON HUMAN PERIPHERAL BLOOD LYMPHOCYTES OF CYCLOSPORINE A, FK-506, AND MYCOPHENOLIC ACID

P. S. Pine, J. Weaver, A. Aszalos, 1991 .

Comparison of the in vitro and biophysical effects of cyclosporine A, FK-506, and mycophenolic acid on human peripheral blood lymphocytes.

P. S. Pine, J. Weaver, A. Aszalos, 1991, Immunopharmacology and immunotoxicology.

Polyionic compounds selectively alter availability of CD4 receptors for HIV coat protein rgp120.

P. S. Pine, P. Gergely, J. Weaver, 1990, AIDS research and human retroviruses.

The interaction of immunosuppressive compounds in tandem stimulated peripheral human lymphocytes.

P. S. Pine, J. Weaver, A. Aszalos, 1994, Immunopharmacology and immunotoxicology.

Structure elucidation of the antibiotic desertomycin through the use of new two-dimensional NMR techniques

A. Bax, A. Aszalos, Z. Dinya, 1987 .

Structure Elucidation of the Antibiotic Desertomycin Through the Use of New Two-Dimensional NMR Techniques

Ad Bax, Adorjan Aszalos, A. Bax, 1987 .

The effect of ion channel blockers, immunosuppressive agents, and other drugs on the activity of the multi‐drug transporter

M. Gottesman, P. S. Pine, J. Weaver, 1993, International journal of cancer.

Cytotoxic and Antitumor Compounds from Fermentations

A. Aszalos, J. Bérdy, A. Aszalós, 1978 .

Combinations of P-glycoprotein blockers, verapamil, PSC833, and cremophor act differently on the multidrug resistance associated protein (MRP) and on P-glycoprotein (Pgp).

D. Ross, J. Yin, A. Aszalos, 1999, Anticancer research.

Quantitation of daunorubicin, doxorubicin, and their aglycones by ion-pair reversed-phase chromatography.

A. Aszalos, A. Haneke, J. Crawford, 1981, Journal of pharmaceutical sciences.

Cyclosporin depolarizes human lymphocytes: earliest observed effect on cell metabolism

S. Damjanovich, L. Trón, M. Balázs, 1987, European journal of immunology.

Lateral diffusion measurements give evidence for association of the Tac peptide of the IL-2 receptor with the T27 peptide in the plasma membrane of HUT-102-B2 T cells.

T. Waldmann, M. Edidin, S. Damjanovich, 1988, Journal of immunology.

Modulation of multidrug resistance in cancer by immunosuppresive agents

A. Aszalos, A. Aszalós, 1995, Pathology & Oncology Research.

Trienine, an antitumor triene antibiotic.

A. Aszalos, R. Robison, P. Lemanski, 1968, The Journal of antibiotics.

Inhibition of the Binding of HIV rgp120 to CD4 by Dyes

P. S. Pine, J. Weaver, A. Aszalos, 1992 .

Specific disengagement of cell-bound anti-LAM-1 (anti-L-selectin) antibodies by aurintricarboxylic acid.

P. S. Pine, J. Weaver, G. Szabó, 1993, Molecular immunology.

Effect of cyclosporin A and ionophores on the intracellular pH of lymphocytes as measured by flow cytometry.

L. Trón, J. Siegel, A. Aszalos, 1989, Biochemical medicine and metabolic biology.

On the biophysics of transmembrane signalling.

S. Damjanovich, L. Trón, M. Balázs, 1988, Molecular immunology.

A semiautomated fluorescence-based cell-to-cell fusion assay for gp120-gp41 and CD4 expressing cells.

P. S. Pine, T. Oravecz, J. Weaver, 1998, Experimental cell research.

Cross-linking of CD4 in a TCR/CD3-juxtaposed inhibitory state: a pFRET study.

P. S. Pine, J. Weaver, P. Rao, 1995, Biophysical journal.

Lymphocyte subpopulation with low membrane potential in the blood of cyclosporin- and prednisone-treated patients: in vivo selectivity for T4 subset.

L. Trón, A. Aszalos, H. Paxton, 1989, Biochemical medicine and metabolic biology.

Different roles for K+ channels in cisplatin-resistant cell lines argue against a critical role for these channels in cisplatin resistance.

M. Gottesman, G. Szakács, J. Annereau, 2005, Anticancer research.

Changes in biophysical parameters of plasma membranes influence cisplatin resistance of sensitive and resistant epidermal carcinoma cells.

M. Gottesman, Paul C. Wang, Xing-jie Liang, 2004, Experimental cell research.

Multidrug transporters as drug targets.

A. Aszalos, X. Liang, 2006, Current drug targets.

Disruption of microfilaments by cytochalasin B decreases accumulation of cisplatin in human epidermal carcinoma and liver carcinoma cell lines

M. Gottesman, Xing-jie Liang, D. Shen, 2008, Cancer Chemotherapy and Pharmacology.

Flow cytometric evaluation of multidrug resistance proteins.

A. Aszalos, B. Taylor, A. Aszalós, 2010, Methods in molecular biology.

Induction of apoptosis in MDR1 expressing cells by daunorubicin with combinations of suboptimal concentrations of P-glycoprotein modulators.

B. Szende, A. Ladányi, J. Bocsi, 2001, Cancer letters.

Early plasma membrane depolarization by alpha interferon: biologic correlation with antiproliferative signal.

A. Aszalos, P. Grimley, A. Aszalós, 1987, Biochemical and biophysical research communications.

Comparison of biophysical parameters of primary low and high metastatic Lewis lung tumor cells.

K. Lapis, A. Aszalos, A. Jeney, 1986, Journal of medicine.

MDR1/P-glycoprotein function. II. Effect of hypotonicity and inhibitors on Cl- efflux and volume regulation.

J. Weaver, A. Aszalos, L. McKinney, 1996, The American journal of physiology.

Cyclosporin elicits a non-responsive state and a shift in K+ fluxes in the early phase of activation of human lymphocytes with anti-CD3.

A. Aszalos, 1991, European journal of pharmacology.

Cyclosporin A depolarizes cytoplasmic membrane potential and interacts with Ca2+ ionophores.

L. Mátyus, S. Damjanovich, M. Balázs, 1986, Biochimica et biophysica acta.

Identification of antibiotic 1037 as toyocamycin.

A. Aszalos, R. Robison, P. Lemanski, 1966, The Journal of antibiotics.

Effect of combination of suboptimal concentrations of P‐glycoprotein blockers on the proliferation of MDR1 gene expressing cells

P. S. Pine, C. Hrycyna, T. Licht, 1996, International journal of cancer.

Analysis of Antitumor Antibiotics by High Pressure Liquid Chromatography (HPLC)

A. Aszalos, A. Aszalós, 1984 .

Depolymerization of microtubules increases the motional freedom of molecular probes in cellular plasma membranes

M. Gottesman, A Aszalos, M M Gottesman, 1985, The Journal of cell biology.

Studies on the action of nystatin on cultured rat myocardial cells and cell membranes, isolated rat hearts, and intact rats.

A. Aszalos, J. Bradlaw, A. el-Hage, 1984, Biochemical pharmacology.

Physico-chemical and microbiological comparison of nystatin, amphotericin A and amphotericin B, and structure of amphotericin A.

A. Bax, P. Roller, C. McNeal, 1985, The Journal of antibiotics.

Phenothiazines in treatment of HIV infection (a review).

A. Aszalos, A. Aszalós, 2003, Acta microbiologica et immunologica Hungarica.

Protein Kinase C Is Involved in the Early Signals of Interferon-α But Not of Interferon-γ in U937 Cells

P. Csermely, A. Aszalos, E. Bálint, 1990 .

Microbiol N-acetylation of daunorubicin and daunorubicinol.

B. K. Hamilton, D. Wareheim, A. Aszalos, 1977, The Journal of antibiotics.

Microbial reduction of the side-chain carbonyl of daunorubicin and N-acetyldaunorubicin.

L. H. Wright, P. Roller, N. Bachur, 1977, The Journal of antibiotics.

FREDERICAMYCIN A, A NEW ANTITUMOR ANTIBIOTIC

R. C. Pandey, Richard J. White, R. Stroshane, 1981 .

Field desorption mass spectrometry in structural studies of polyene macrolide antibiotics: isolation and early identification of a pentaene macrolide antibiotic.

R. C. Pandey, J. C. Cook, K. Rinehart, 1980, Biomedical mass spectrometry.

Antitumor compounds of natural origin : chemistry and biochemistry

A. Aszalos, 1981 .

Fast determination of tetracycline antibiotics in different media by high-performance liquid chromatography

A. Aszalos, 1985 .

Thin Layer Chromatographic Systems for the Classification and Identification of Antibiotics

H. Issaq, A. Aszalos, 1980 .

Classification of crude antibiotics by instant thin-layer chromatography (ITLC).

A. Aszalos, S. Davis, D. Frost, 1968, Journal of chromatography.

Prevention of binding of rgp120 by anti-HIV active tannins.

P. S. Pine, Y. Cheng, K. Lee, 1992, Biochemical pharmacology.

Chemistry of saramycetin. II. Sequence studies.

O. Kocy, A. Aszalos, J. Kirschbaum, 1969, Journal of antibiotics (Tokyo. 1968).

Quantitation of amphotericins by reverse-phase high-performance liquid chromatography.

A. Aszalos, M. Margosis, 1984, Journal of pharmaceutical sciences.

Macrophage cytostasis and T and B cell blastogenic transformation in mice treated with nystatin.

D. L. Klein, A. Aszalos, J. Pearson, 1980, Journal of immunopharmacology.

Differential Potentiation by Nystatin of the Effect of Antibiotics on Yeast and Mammalian Cells

A. Aszalos, 1975, Antimicrobial Agents and Chemotherapy.

Aggregates of antibiotics: stabilities; modes of binding, and methods of disruption of the aggregates of saramycetin and prasinomycin.

A. Aszalos, J. Kirschbaum, F. Weisenborn, 1970, Journal of colloid and interface science.

Molecular weight of the antifungal antibiotic saramycetin

A. Aszalos, J. Kirschbaum, 1967 .

Chemistry of saramycetin. I. General features and structure of saramycetic acid I.

A. Aszalos, A. Cohen, J. Alicino, 1967, Antimicrobial agents and chemotherapy.

High-performance liquid chromatography in the analysis of antibiotics

A. Aszalos, M. Margosis, T. Alexander, 1982 .

Physicochemical and biological comparison of polyene macrolide antibiotics fungichromin, lagosin and cogomycin.

R. C. Pandey, A. Aszalos, J. Brajtburg, 1982, The Journal of antibiotics.

Anti-psychotic drugs reverse multidrug resistance of tumor cell lines and human AML cells ex-vivo.

J. Molnár, I. Ocsovszki, D. Szabó, 1999, Cancer letters.

Analyses of tetracyline antibiotics by reversed-phase high-performance liquid chromatography

A. Aszalos, C. Haneke, M. Hayden, 1982 .

Dynamic analyses of lymphoblast membranes exposed to alpha interferon using flow cytometry and fluorescence recovery after photobleaching.

P. S. Pine, A. Aszalos, E. Bálint, 1988, Scanning microscopy.

Metal complexes of phenothiazine based pharmaceuticals: A study of their chemistry and biological effects

T. Hambley, J. Molnár, A. Hevér, 1995 .

High-performance liquid chromatographic determination of components of bleomycin preparations.

A. Aszalos, J. Crawford, N. Kantor, 1981, Journal of pharmaceutical sciences.

[8] Thin-layer chromatography of antibiotics

A. Aszalos, D. Frost, A. Aszalós, 1975 .

Septacidin analogues.

J. Dutcher, A. Aszalos, P. Lemanski, 1965, Antimicrobial agents and chemotherapy.

Molecular events as targets of anticancer drug therapy

A. Aszalos, S. Eckhardt, A. Aszalós, 2008, Pathology & Oncology Research.

Plasma membrane biophysical properties linked to the antiproliferative effect of interferon-alpha.

K. Zoon, A. Aszalos, E. Bálint, 2005, Acta microbiologica et immunologica Hungarica.

Alpha interferon accelerates lateral diffusion of Daudi cell surface differentiation antigens: measurement by fluorescence redistribution after photobleaching.

A. Aszalos, E. Bálint, P. Grimley, 1988, Biochemical and biophysical research communications.

Metabolic products of microorganisms. LXXXVI. Structure of cinerubine A.

A. Aszalos, B. Berk, M. Jelínek, 1964 .

RUBIFLAVIN, A TOXIC ANTITUMOR ANTIBIOTIC.

A. Aszalos, B. Berk, M. Jelínek, 1964, Antimicrobial agents and chemotherapy.

Reversible dissociation of L-asparaginase of Escherichia coli B.

O. Kocy, J. Casey, A. Aszalos, 1972, Journal of pharmaceutical sciences.

Thin-layer chromatographic classification of antibiotics exhibiting antitumor properties.

H. Issaq, A. Aszalos, T. Wei, 1977, Journal of chromatography.

Flow cytometric resonance energy transfer measurements support the association of a 95-kDa peptide termed T27 with the 55-kDa Tac peptide.

T. Waldmann, C. Goldman, S. Damjanovich, 1987, Proceedings of the National Academy of Sciences of the United States of America.

SIRT1 Contributes in Part to Cisplatin Resistance in Cancer Cells by Altering Mitochondrial Metabolism

M. Gottesman, Xing-jie Liang, T. Finkel, 2008, Molecular Cancer Research.

Drug-drug interactions affected by the transporter protein, P-glycoprotein (ABCB1, MDR1) II. Clinical aspects.

Adorjan Aszalos, A. Aszalos, A. Aszalós, 2007, Drug discovery today.

Modern analysis of antibiotics

A. Aszalos, 1986 .

Role of ATP-binding cassette (ABC) transporters in interactions between natural products and drugs.

A. Aszalos, A. Aszalós, 2008, Current drug metabolism.

P-Glycoprotein-based drug-drug interactions: preclinical methods and relevance to clinical observations

A. Aszalos, A. Aszalós, 2004, Archives of pharmacal research.

Influence of antipsychotic, antiemetic, and Ca(2+) channel blocker drugs on the cellular accumulation of the anticancer drug daunorubicin: P-glycoprotein modulation.

A. Knapton, J. Peggins, T. Licht, 2000, The Journal of pharmacology and experimental therapeutics.

Intracellular pH does not affect drug extrusion by P-glycoprotein.

T. Márián, L. Trón, K. Goda, 1996, Journal of photochemistry and photobiology. B, Biology.

MDR1/P-glycoprotein function. I. Effect of hypotonicity and inhibitors on rhodamine 123 exclusion.

M. Gottesman, J. Weaver, A. Aszalos, 1996, The American journal of physiology.

Behavior of N-acylated daunorubicins in MDR1 gene transfected and parental cells.

M. Gottesman, P. S. Pine, A. Aszalos, 1995, Biochemical pharmacology.

Structure of Enzymes

A. Aszalos, A. Aszalós, 1978 .

Modulation of the anti-proliferative signal of interferon-α by tamoxifen in U937 cells

A. Aszalos, E. Bálint, P. Grimley, 1992 .

Cytoplasmic membrane potential of mouse lymphocytes is decreased by cyclosporins.

L. Mátyus, S. Damjanovich, M. Balázs, 1986, Molecular immunology.

Inhibition of the transport function of membrane proteins by some substituted phenothiazines in E. coli and multidrug resistant tumor cells.

J. Molnár, J. Fischer, A. Hevér, 1997, Anticancer research.

Considerations in Assessing the Immunotoxic Potential of Investigational Drugs

J. Weaver, C. Ahn, K. Hastings, 1997 .

Protein kinase C is involved in the early signals of interferon-alpha but not of interferon-gamma in U937 cells.

P. Csermely, P Csermely, E Balint, 1990, Journal of interferon research.

Subambient Infrared Spectra of Several Aminoglycoside Antibiotics

A. Aszalos, 1984 .

Mobility of HLA Class I antigen influenced by anti-CD-4 monoclonal antibody in lymphocyte membranes: a flow cytometric energy transfer, fluorescence photobleaching recovery, and rotational relaxation study

Laszlo Balkay, Sandor Damjanovich, Laszlo Pohubi, 1990, Photonics West - Lasers and Applications in Science and Engineering.

Comparative study of peptide-type antibiotics in reversed-phase thin-layer chromatography and reversed-phase high-performance liquid chromatography

A. Aszalos, A. Aquilar, A. Aszalós, 1984 .

Laser scanning and confocal microscopy of daunorubicin, doxorubicin, and rhodamine 123 in multidrug-resistant cells.

M. Gottesman, P. S. Pine, J. Weaver, 1991, Experimental cell research.

Biochemical and clinical aspects of efflux pump related resistance to anti-cancer drugs.

D. Ross, A. Aszalos, Adorjan Aszalos, 1998, Anticancer research.

Epitope mapping by photobleaching fluorescence resonance energy transfer measurements using a laser scanning microscope system.

P S Pine, P. S. Pine, J L Weaver, 1992, Biophysical journal.